CoChat

Immunogenicity of Therapeutic Proteins: The Use of Animal Models

Open access
Brinks, Vera, Jiskoot, Wim, Schellekens, Huub · 2011 · Pharmaceutical Research

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

Immunogenicity of therapeutic proteins lowers patient well-being and drastically increases therapeutic costs. Preventing immunogenicity is an important issue to consider when developing novel therapeutic proteins and applying them in the clinic. Animal models are increasingly used to study immunogenicity of therapeutic proteins. They are employed as predictive tools to assess different aspects of immunogenicity during drug development and have become vital in studying the mechanisms underlying immunogenicity of therapeutic proteins. However, the use of animal models needs critical evaluation. Because of species differences, predictive value of such models is limited, and mechanistic studies can be restricted. This review addresses the suitability of animal models for immunogenicity prediction and summarizes the insights in immunogenicity that they have given so far.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11095-011-0523-5

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Research works printed but not linked: 2

  1. EMA. Guideline on immunogenicity assessment of biotechnology-derived therapeutic proteins. 2007. Ref Type: Conference Proceeding
  2. Center for Biologics Evaluation and Research. Meeting of the biological response modifiers advisory committee. July 15, Bethesda MD. Food and Drug Administration. 1999. Ref Type: Conference Proceeding

Cited by

See all 187

Metadata

Authors
Brinks, V., Jiskoot, W., & Schellekens, H.
Affiliations
  • Utrecht University (NL)
  • Leiden University (NL)
Corresponding author
Brinks, Vera
Venue
Pharmaceutical Research
Published
2011-07-09
Volume
28
Issue
10
Pages
2379-2385
ISSN
  • 0724-8741 (ISSN-L)
  • 1573-904X
OpenAlex
W2114029270
Cited by
164
References
40
Citations by year
2026: 6 · 2025: 7 · 2024: 6 · 2023: 6 · 2022: 5 · 2021: 7 · 2020: 9 · 2019: 16 · 2018: 11 · 2017: 8 · 2016: 10 · 2015: 17 · 2014: 17 · 2013: 19 · 2012: 18
FWCI
1.58
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Pharmaceutical Research (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Biosimilars and Bioanalytical Methods
  • Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
Keywords
immunogenicity, therapeutic proteins, animal models, species differences, drug development
MeSH terms
Animals, Biological Products, Drug Evaluation, Preclinical, Humans, Predictive Value of Tests, Proteins, Models, Animal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immunogenicity of Therapeutic Proteins: The Use of Animal Models. https://app.cochat.ai/papers/10.1007/s11095-011-0523-5
The paper
Brinks, V., Jiskoot, W., & Schellekens, H. (2011). Immunogenicity of Therapeutic Proteins: The Use of Animal Models. Pharmaceutical Research. https://doi.org/10.1007/s11095-011-0523-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.